Combining Awareness and Innovation

from Applied Clinical Trials · host Applied Clinical Trials

Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences discusses how he chose to focus his career path on HIV research and how increased awareness combined with new innovations have advanced the therapeutic area. He also touches on the operational challenges he is currently seeing within HIV trials.

Episode metadata supplied by the publisher feed · Published Dec 1, 2023

Embed this episode

Attribution link and audio player

What this episode covers

Jared Baeten, Vice President, Clinical Development, HIV Franchise Head at Gilead Sciences highlights how awareness and clinical innovation have transformed research in the HIV space.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Combining Awareness and Innovation

0:00 24:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Applied Clinical Trials?

This episode is 24 minutes long.

When was this Applied Clinical Trials episode published?

This episode was published on December 1, 2023.

Can I download this Applied Clinical Trials episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!